'Vaccinations Should Not Be Free For Non-residents'

"); jQuery("#212 h3").html("

Related News Programmes

"); });

2022-12-26 HKT 12:10

Share this story

facebook

  • Officials say they aim to implement a plan to reopen the Hong Kong-mainland border by mid-January. File photo: RTHK

    Officials say they aim to implement a plan to reopen the Hong Kong-mainland border by mid-January. File photo: RTHK

A virologist at the University of Hong Kong, Jin Dong-yan, said on Monday he expects the opening of the border between Hong Kong and the mainland to bring "manageable risks" to the SAR, as he and the head of a pharmacists' group both called on authorities to consider charging non-residents for Covid vaccinations here.

Officials have said they aim to start allowing more people to flow through the Hong Kong-mainland border by the middle of next month.

"There's definitely risk as many big cities in mainland China are going through a tsunami phase, so they for sure have relatively more infected people," Jin said on an RTHK programme.

He pointed out that Hong Kong could see an increase in cases, as well as demand for vaccinations and antiviral drugs, when more people are allowed to cross the border.

"But I think all the risks are manageable and we should have a bit more confidence in ourselves," the professor in precision medicine added.

Jin said he believes infected incoming travellers will mostly have mild cases of Covid-19 and that PCR tests will be able to screen them out.

On the question of surging demand for drugs and vaccines, meanwhile, he had a proposal.

"As there are sufficient vaccines in the world, perhaps if we save up more and treat it as a business, that won't be a loss for us," the virologist said.

Non-residents who are not studying or working in Hong Kong should be charged for vaccinations, he continued.

Meanwhile, the president of The Society of Hospital Pharmacists, William Chui, also called on the government to charge non-residents for vaccinations, warning that free jabs and treatments could prompt too many to cross the border to access medical services here and burden the local system.

"People from mainland China demand for more symptomatic relief medications," he said. "They may go to Hong Kong to get more medications. At the moment they are looking for medications on the mainland but the supply is very limited."

Chui urged local pharmaceutical companies to quickly boost their production now in view of surging demand to come.

"The Hong Kong government should contact the local drug manufacturers to increase the manufacturing of paracetamol and also other symptomatic relief medications which may be in great demand by the people of the mainland and the people of Hong Kong."

RECENT NEWS

Adyen And JCB Launch Card-on-File Tokenisation To Boost Payment Security

Adyen and JCB Co., Ltd. have launched JCB’s card-on-file (COF) tokenisation service, designed to improve the securit... Read more

Hong Kongs Cashless Future Is Closer Than You Think

A recent Worldpay report indicated that the digital wallets Hong Kong has could dominate its payment landscape by 2030.... Read more

HKMA Green Fintech Competition Open For Submissions

The Hong Kong Monetary Authority (HKMA) announced the launch of the 2025 Green Fintech Competition on 9 May 2025. It is... Read more

HSBC Launches Refreshed Hong Kong App With Smarter, Personalised Features

HSBC Hong Kong announced the launch of it refreshed HSBC HK App on 7 May 2025, set to roll out by phases beginning mid-... Read more

Chubb Life Hong Kong Launches Health Up Insurance For The Tech-Savvy

Chubb Life Hong Kong introduced the Health Up Insurance Plan (Health Up) on 7 May 2025. The Chubb Health Up Insurance d... Read more

Ant International Eyes Hong Kong IPO, In Talks With Regulators

Ant Group, a subsidiary of China’s Alibaba Group, is reportedly planning to list its overseas branch, Ant Internation... Read more